| 000 | 01771 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250517061806.0 | ||
| 264 | 0 | _c20160620 | |
| 008 | 201606s 0 0 eng d | ||
| 022 | _a1555-7162 | ||
| 024 | 7 |
_a10.1016/j.amjmed.2015.10.015 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBrilliant, Murray H | |
| 245 | 0 | 0 |
_aMining Retrospective Data for Virtual Prospective Drug Repurposing: L-DOPA and Age-related Macular Degeneration. _h[electronic resource] |
| 260 |
_bThe American journal of medicine _cMar 2016 |
||
| 300 |
_a292-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAge Distribution |
| 650 | 0 | 4 | _aAge of Onset |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntiparkinson Agents _xpharmacology |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aData Mining |
| 650 | 0 | 4 |
_aEye Proteins _xphysiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLevodopa _xpharmacology |
| 650 | 0 | 4 |
_aMacular Degeneration _xepidemiology |
| 650 | 0 | 4 |
_aMembrane Glycoproteins _xphysiology |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_aUnited States _xepidemiology |
| 700 | 1 | _aVaziri, Kamyar | |
| 700 | 1 | _aConnor, Thomas B | |
| 700 | 1 | _aSchwartz, Stephen G | |
| 700 | 1 | _aCarroll, Joseph J | |
| 700 | 1 | _aMcCarty, Catherine A | |
| 700 | 1 | _aSchrodi, Steven J | |
| 700 | 1 | _aHebbring, Scott J | |
| 700 | 1 | _aKishor, Krishna S | |
| 700 | 1 | _aFlynn, Harry W | |
| 700 | 1 | _aMoshfeghi, Andrew A | |
| 700 | 1 | _aMoshfeghi, Darius M | |
| 700 | 1 | _aFini, M Elizabeth | |
| 700 | 1 | _aMcKay, Brian S | |
| 773 | 0 |
_tThe American journal of medicine _gvol. 129 _gno. 3 _gp. 292-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.amjmed.2015.10.015 _zAvailable from publisher's website |
| 999 |
_c25409884 _d25409884 |
||